{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:09:21Z","timestamp":1791428961663,"version":"4.3.3"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.vaccine.2025.126779","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:38:55Z","timestamp":1739320735000},"page":"126779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["BECC-engineered live-attenuated Shigella vaccine candidates display reduced endotoxicity with robust immunogenicity in mice"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4918-6179","authenticated-orcid":false,"given":"Matthew E.","family":"Sherman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Michalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7445-2796","authenticated-orcid":false,"given":"Sayan","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1659-2771","authenticated-orcid":false,"given":"Hyojik","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3033-3591","authenticated-orcid":false,"given":"Lakshmi","family":"Chandrasekaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3651-5167","authenticated-orcid":false,"given":"Timothy R.","family":"O'Meara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1095-6156","authenticated-orcid":false,"given":"David J.","family":"Dowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5859-1945","authenticated-orcid":false,"given":"Ofer","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoshana","family":"Barnoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7790-1286","authenticated-orcid":false,"given":"Malabi","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5016-8694","authenticated-orcid":false,"given":"Robert K.","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10053","key":"10.1016\/j.vaccine.2025.126779_bb0005","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: a systematic analysis for the global burden of disease study 2015","volume":"388","author":"Vos","year":"2016","journal-title":"Lancet"},{"issue":"10053","key":"10.1016\/j.vaccine.2025.126779_bb0010","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the global burden of disease study 2015","volume":"388","author":"Wang","year":"2016","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126779_bb0015","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S1473-3099(18)30362-1","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the global burden of disease study 2016","volume":"18","author":"Troeger","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126779_bb0020","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3390\/microorganisms9071382","article-title":"Vaccines for protecting infants from bacterial causes of diarrheal disease","volume":"9","author":"Walker","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.vaccine.2025.126779_bb0025","series-title":"Mucosal vaccines","first-page":"515","article-title":"Oral Shigella Vaccines","author":"Pasetti","year":"2020"},{"issue":"10051","key":"10.1016\/j.vaccine.2025.126779_bb0030","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0140-6736(16)31529-X","article-title":"Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study","volume":"388","author":"Liu","year":"2016","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126779_bb0035","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S1473-3099(18)30475-4","article-title":"Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the global burden of disease study 1990\u20132016","volume":"18","author":"Khalil","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"sup1","key":"10.1016\/j.vaccine.2025.126779_bb0040","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1080\/20469047.2017.1409454","article-title":"Guidelines for the treatment of dysentery (shigellosis): a systematic review of the evidence","volume":"38","author":"Williams","year":"2018","journal-title":"Paediatrics Int Child Health"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126779_bb0045","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1016\/S2214-109X(18)30483-2","article-title":"Burden of enterotoxigenic Escherichia coli and shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysis","volume":"7","author":"Anderson","year":"2019","journal-title":"Lancet Glob Health"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126779_bb0050","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1128\/CMR.00032-07","article-title":"Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion","volume":"21","author":"Schroeder","year":"2008","journal-title":"Clin Microbiol Rev"},{"issue":"10122","key":"10.1016\/j.vaccine.2025.126779_bb0055","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0140-6736(17)33296-8","article-title":"Shigellosis","volume":"391","author":"Kotloff","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126779_bb0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00203-020-02034-3","article-title":"Shigella sonnei: virulence and antibiotic resistance","volume":"203","author":"Shad","year":"2021","journal-title":"Arch Microbiol"},{"key":"10.1016\/j.vaccine.2025.126779_bb0065","series-title":"Increase in extensively drug-resistant shigellosis in the United States","author":"Network, C.H.A","year":"2023"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126779_bb0070","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nrgastro.2013.12","article-title":"Progress and pitfalls in Shigella vaccine research","volume":"10","author":"Barry","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126779_bb0075","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrmicro1662","article-title":"Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road","volume":"5","author":"Levine","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126779_bb0080","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1586\/erv.09.127","article-title":"Inactivated and subunit vaccines to prevent shigellosis","volume":"8","author":"Kaminski","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126779_bb0085","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00583-17","article-title":"Assembly, biochemical characterization, immunogenicity, Adjuvanticity, and efficacy of Shigella artificial Invaplex","volume":"3","author":"Turbyfill","year":"2018","journal-title":"mSphere"},{"issue":"42","key":"10.1016\/j.vaccine.2025.126779_bb0090","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.1016\/j.vaccine.2023.08.051","article-title":"GMP manufacture of Shigella flexneri 2a artificial Invaplex (Invaplex(AR)) and evaluation in a phase 1 open-label, dose escalating study administered intranasally to healthy, adult volunteers","volume":"41","author":"Duplessis","year":"2023","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126779_bb0095","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00073-23","article-title":"Development of the Shigella flexneri 2a, 3a, 6, and S. sonnei artificial Invaplex (Invaplex(AR)) vaccines","volume":"8","author":"Turbyfill","year":"2023","journal-title":"mSphere"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126779_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035616","article-title":"High yield production process for Shigella outer membrane particles","volume":"7","author":"Berlanda Scorza","year":"2012","journal-title":"PLoS One"},{"issue":"36","key":"10.1016\/j.vaccine.2025.126779_bb0105","doi-asserted-by":"crossref","first-page":"24922","DOI":"10.1074\/jbc.M114.566570","article-title":"Modulation of Endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid a modifications","volume":"289","author":"Rossi","year":"2014","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126779_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134478","article-title":"Production of a Shigella sonnei vaccine based on generalized modules for membrane antigens (GMMA), 1790GAHB","volume":"10","author":"Gerke","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126779_bb0115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41541-024-00822-2","article-title":"Putative correlates of protection against shigellosis assessing immunomarkers across responses to S. sonnei investigational vaccine","volume":"9","author":"Conti","year":"2024","journal-title":"NPJ Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126779_bb0120","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1586\/14760584.5.5.669","article-title":"Live-attenuated Shigella vaccines","volume":"5","author":"Venkatesan","year":"2006","journal-title":"Expert Rev Vaccines"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126779_bb0125","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/cid\/ciu468","article-title":"Shigella isolates from the global enteric multicenter study inform vaccine development","volume":"59","author":"Livio","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126779_bb0130","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/IAI.67.7.3437-3443.1999","article-title":"Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602","volume":"67","author":"Coster","year":"1999","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126779_bb0135","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1128\/iai.64.4.1190-1196.1996","article-title":"Induction of a local anti-IpaC antibody response in mice by use of a Shigella flexneri 2a vaccine candidate: implications for use of IpaC as a protein carrier","volume":"64","author":"Barzu","year":"1996","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126779_bb0140","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1128\/IAI.66.9.4572-4576.1998","article-title":"Construction of a stable attenuated Shigella sonnei DeltavirG vaccine strain, WRSS1, and protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model","volume":"66","author":"Hartman","year":"1998","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126779_bb0145","first-page":"88","article-title":"Safety and colonization of two novel VirG(IcsA)-based live Shigella sonnei vaccine strains in rhesus macaques (Macaca mulatta)","volume":"58","author":"Collins","year":"2008","journal-title":"Comp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126779_bb0150","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.vaccine.2009.11.001","article-title":"Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity","volume":"28","author":"Barnoy","year":"2010","journal-title":"Vaccine"},{"issue":"37","key":"10.1016\/j.vaccine.2025.126779_bb0155","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1016\/j.vaccine.2011.04.115","article-title":"Shigella sonnei vaccine candidates WRSs2 and WRSs3 are as immunogenic as WRSS1, a clinically tested vaccine candidate, in a primate model of infection","volume":"29","author":"Barnoy","year":"2011","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126779_bb0160","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4161\/gmic.2.4.17042","article-title":"Further characterization of Shigella sonnei live vaccine candidates WRSs2 and WRSs3-plasmid composition, invasion assays and Sereny reactions","volume":"2","author":"Bedford","year":"2011","journal-title":"Gut Microbes"},{"issue":"34","key":"10.1016\/j.vaccine.2025.126779_bb0165","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1016\/j.vaccine.2012.05.003","article-title":"Two live attenuated Shigella flexneri 2a strains WRSf2G12 and WRSf2G15: a new combination of gene deletions for 2nd generation live attenuated vaccine candidates","volume":"30","author":"Ranallo","year":"2012","journal-title":"Vaccine"},{"issue":"37","key":"10.1016\/j.vaccine.2025.126779_bb0170","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1016\/j.vaccine.2013.04.076","article-title":"Evaluation of virulent and live Shigella sonnei vaccine candidates in a gnotobiotic piglet model","volume":"31","author":"Jeong","year":"2013","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2025.126779_bb0175","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.vaccine.2013.12.068","article-title":"Oral administration of live Shigella vaccine candidates in rhesus monkeys show no evidence of competition for colonization and immunogenicity between different serotypes","volume":"32","author":"Ranallo","year":"2014","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126779_bb0180","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1128\/IAI.70.4.2016-2021.2002","article-title":"Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults","volume":"70","author":"Kotloff","year":"2002","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126779_bb0185","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/IAI.72.2.923-930.2004","article-title":"Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in north American volunteers","volume":"72","author":"Katz","year":"2004","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126779_bb0190","doi-asserted-by":"crossref","first-page":"8027","DOI":"10.1128\/IAI.73.12.8027-8032.2005","article-title":"Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteers","volume":"73","author":"Orr","year":"2005","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126779_bb0195","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.vaccine.2010.10.035","article-title":"Safety, dose, immunogenicity, and transmissibility of an oral live attenuated Shigella flexneri 2a vaccine candidate (SC602) among healthy adults and school children in Matlab, Bangladesh","volume":"29","author":"Rahman","year":"2011","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126779_bb0200","first-page":"564","article-title":"Clinical trial of an Oral live Shigella sonnei vaccine candidate, WRSS1, in thai adults clinical and vaccine","volume":"23","author":"Pitisuttithum","year":"2016","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126779_bb0205","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1080\/21645515.2019.1575165","article-title":"A phase I trial of WRSS1, a Shigella sonnei live oral vaccine in Bangladeshi adults and children","volume":"15","author":"Raqib","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"32","key":"10.1016\/j.vaccine.2025.126779_bb0210","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1016\/j.vaccine.2018.06.063","article-title":"A phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonnei","volume":"36","author":"Frenck","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126779_bb0215","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrmicro1068","article-title":"LPS, TLR4 and infectious disease diversity","volume":"3","author":"Miller","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2025.126779_bb0220","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.12688\/f1000research.11388.1","article-title":"Bacterial lipids: powerful modifiers of the innate immune response","volume":"6","author":"Chandler","year":"2017","journal-title":"F1000Research"},{"key":"10.1016\/j.vaccine.2025.126779_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585146","article-title":"Lipopolysaccharide recognition in the crossroads of TLR4 and Caspase-4\/11 mediated inflammatory pathways","volume":"11","author":"Zamyatina","year":"2020","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126779_bb0230","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.bbalip.2017.01.004","article-title":"Lipid a structural modifications in extreme conditions and identification of unique modifying enzymes to define the toll-like receptor 4 structure-activity relationship","volume":"1862","author":"Scott","year":"2017","journal-title":"Biochimica et Biophysica Acta (BBA) - molecular and cell biology of Lipids"},{"issue":"7242","key":"10.1016\/j.vaccine.2025.126779_bb0235","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/nature07830","article-title":"The structural basis of lipopolysaccharide recognition by the TLR4\u2013MD-2 complex","volume":"458","author":"Park","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126779_bb0240","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.biochem.76.010307.145803","article-title":"Lipid a modification Systems in Gram-Negative Bacteria","volume":"76","author":"Raetz","year":"2007","journal-title":"Annu Rev Biochem"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126779_bb0245","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41579-019-0201-x","article-title":"Pushing the envelope: LPS modifications and their consequences","volume":"17","author":"Simpson","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2025.126779_bb0250","first-page":"358,667","article-title":"Immunotherapeutic Potential of Modified Lipooligosaccharides\/Lipid A","volume":"10","author":"Ernst","year":"2019","journal-title":"US Patent"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126779_bb0255","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2180-6-39","article-title":"Fast, easy and efficient: site-specific insertion of transgenes into Enterobacterial chromosomes using Tn7 without need for selection of the insertion event","volume":"6","author":"McKenzie","year":"2006","journal-title":"BMC Microbiol"},{"issue":"21","key":"10.1016\/j.vaccine.2025.126779_bb0260","doi-asserted-by":"crossref","first-page":"7460","DOI":"10.1021\/acs.analchem.1c05394","article-title":"Lipid a structural determination from a single Colony","volume":"94","author":"Yang","year":"2022","journal-title":"Anal Chem"},{"key":"10.1016\/j.vaccine.2025.126779_bb0265","series-title":"The Shigella Vaccines Pipeline Vaccines (Basel)","first-page":"9","volume":"10","author":"MacLennan","year":"2022"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126779_bb0270","doi-asserted-by":"crossref","first-page":"e00417","DOI":"10.1128\/mBio.00492-17","article-title":"Rationally designed TLR4 ligands for vaccine adjuvant discovery","volume":"8","author":"Gregg","year":"2017","journal-title":"mBio"},{"issue":"28","key":"10.1016\/j.vaccine.2025.126779_bb0275","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1016\/j.vaccine.2018.05.101","article-title":"A lipid A-based TLR4 mimetic effectively adjuvants a Yersinia pestis rF-V1 subunit vaccine in a murine challenge model","volume":"36","author":"Gregg","year":"2018","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.vaccine.2025.126779_bb0280","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.vaccine.2021.06.085","article-title":"Novel TLR4 adjuvant elicits protection against homologous and heterologous influenza a infection","volume":"39","author":"Haupt","year":"2021","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126779_bb0285","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.vaccine.2020.11.066","article-title":"Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonists","volume":"39","author":"Zacharia","year":"2021","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126779_bb0290","article-title":"Position-specific secondary acylation determines detection of lipid a by murine TLR4 and Caspase-11","volume":"90","author":"Alexander-Floyd","year":"2022","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126779_bb0295","article-title":"Lipid a variants activate human TLR4 and the noncanonical Inflammasome differently and require the Core oligosaccharide for Inflammasome activation","volume":"90","author":"Harberts","year":"2022","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126779_bb0300","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41598-023-27965-x","article-title":"Enhancing the protection of influenza virus vaccines with BECC TLR4 adjuvant in aged mice","volume":"13","author":"Haupt","year":"2023","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126779_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175936","article-title":"Human alkaline phosphatase dephosphorylates microbial products and is elevated in preterm neonates with a history of late-onset sepsis","volume":"12","author":"Pettengill","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126779_bb0310","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.4049\/jimmunol.168.10.5240","article-title":"Two msbB genes encoding maximal acylation of lipid a are required for invasive Shigella flexneri to mediate inflammatory rupture and destruction of the intestinal epithelium","volume":"168","author":"D\u2019Hauteville","year":"2002","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126779_bb0315","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1128\/IAI.00533-09","article-title":"Virulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutants","volume":"78","author":"Ranallo","year":"2010","journal-title":"Infect Immun"},{"issue":"14","key":"10.1016\/j.vaccine.2025.126779_bb0320","doi-asserted-by":"crossref","first-page":"9677","DOI":"10.1074\/jbc.274.14.9677","article-title":"Effect of cold shock on lipid a biosynthesis in Escherichia coli. Induction at 12 degrees C of an acyltransferase specific for palmitoleoyl-acyl carrier protein","volume":"274","author":"Carty","year":"1999","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126779_bb0325","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrmicro3047","article-title":"Fortifying the barrier: the impact of lipid a remodelling on bacterial pathogenesis","volume":"11","author":"Needham","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2025.126779_bb0330","series-title":"Cold Spring Harbor","author":"Sambrook","year":"2001"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126779_bb0335","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1128\/IAI.01242-06","article-title":"Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis","volume":"75","author":"Stokes","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2025.126779_bb0340","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2164-9-75","article-title":"The RAST server: rapid annotations using subsystems technology","volume":"9","author":"Aziz","year":"2008","journal-title":"BMC Genomics"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126779_bb0345","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78401-3","article-title":"Rapid microbial identification and colistin resistance detection via MALDI-TOF MS using a novel on-target extraction of membrane lipids","volume":"10","author":"Sorensen","year":"2020","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126779_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044913","article-title":"mMass as a software tool for the annotation of cyclic peptide tandem mass spectra","volume":"7","author":"Niedermeyer","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.126779_bb0355","article-title":"Purification and visualization of lipopolysaccharide from gram-negative bacteria by hot aqueous-phenol extraction","volume":"63","author":"Davis","year":"2012","journal-title":"J Vis Exp"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126779_bb0360","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126779_bb0365","doi-asserted-by":"crossref","first-page":"618","DOI":"10.4049\/jimmunol.165.2.618","article-title":"Cutting edge: Repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2","volume":"165","author":"Hirschfeld","year":"2000","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126779_bib366","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1128\/JB.00151-08","article-title":"Differential regulation by magnesium of the two MsbB paralogs of Shigella flexneri","volume":"190","author":"Goldman","year":"2008","journal-title":"J Bacteriol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25000763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25000763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T15:29:16Z","timestamp":1741793356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25000763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":74,"alternative-id":["S0264410X25000763"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126779","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BECC-engineered live-attenuated Shigella vaccine candidates display reduced endotoxicity with robust immunogenicity in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126779","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126779"}}